Concepedia

Fludarabine-based Regimens

Fludarabine-Based Regimens is a chemotherapeutic treatment protocol that belongs to the class of nucleoside analog combination therapies and is distinguished by its incorporation of fludarabine as the foundational cytotoxic agent, typically employed in the management of hematologic malignancies such as chronic lymphocytic leukemia and non-Hodgkin lymphoma.

1.1K

Publications

70.7K

Citations

6.4K

Authors

1.7K

Institutions

Publications per year

2017–2026

127

Parents

Publications

1.1K

Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial

Michael Hallek, Kirsten Fischer, Guenter Fingerle-Rowson et al. · The Lancet · 2010 · 1.9K citations

, , +10

Fludarabine Compared with Chlorambucil as Primary Therapy for Chronic Lymphocytic Leukemia

Bercedis L. Peterson, Frederick R. Appelbaum, Jonathan E. Kolitz et al. · New England Journal of Medicine · 2000 · 1K citations · Full text

, , +10

Early Results of a Chemoimmunotherapy Regimen of Fludarabine, Cyclophosphamide, and Rituximab As Initial Therapy for Chronic Lymphocytic Leukemia

Michael J. Keating, Susan O’Brien, Maher Albitar et al. · Journal of Clinical Oncology · 2005 · 951 citations · Full text

, , +14

Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study

Michael J. Keating, Ian W. Flinn, Vinay Jain et al. · Blood · 2002 · 946 citations · Full text

, , +8

Transplant-lite: induction of graft-versus-malignancy using fludarabine-based nonablative chemotherapy and allogeneic blood progenitor-cell transplantation as treatment for lymphoid malignancies.

Issa F. Khouri, Michael J. Keating, M Körbling et al. · Journal of Clinical Oncology · 1998 · 927 citations

, , +17

1–5 of 1.1K

Authors

6.4K

  1. HM
    Hagop M. Kantarjian

    The University of Texas MD Anderson Cancer Center, United States

    89 publications · 10.2K citations

    48

    h-index

  2. MJ
    Michael J. Keating

    The University of Texas MD Anderson Cancer Center, United States

    92 publications · 11.1K citations

    46

    h-index

  3. WP
    William Plunkett

    The University of Texas MD Anderson Cancer Center, United States

    45 publications · 5.6K citations

    35

    h-index

  4. MH
    Michael Hallek

    University of Cologne, Germany

    47 publications · 6.4K citations

    31

    h-index

  5. SL
    Susan Lerner

    The University of Texas MD Anderson Cancer Center, United States

    41 publications · 5.2K citations

    30

    h-index

1–5 of 6.4K

Institutions

1.7K

  1. The University of Texas MD Anderson Cancer Center

    Houston, United States

    75 h-index

    1.6K publications

    176.8K citations

  2. University of Cologne

    Cologne, Germany

    28 h-index

    223 publications

    40K citations

  3. The Ohio State University

    Columbus, United States

    25 h-index

    102 publications

    16.1K citations

  4. Universität Ulm

    Ulm, Germany

    23 h-index

    118 publications

    16.1K citations

  5. Sorbonne Université

    Paris, France

    22 h-index

    86 publications

    5.4K citations

  6. Fred Hutch Cancer Center

    Seattle, United States

    21 h-index

    125 publications

    5.8K citations

  7. National Cancer Institute

    Bethesda, United States

    21 h-index

    76 publications

    5.1K citations

  8. University of Bologna

    Bologna, Italy

    21 h-index

    195 publications

    7.6K citations

1–8 of 1.7K

Venues

  1. Journal of Clinical Oncology

    96 publications · 15.8K citations

    66

    h-index

  2. Blood

    161 publications · 16.7K citations

    65

    h-index

  3. PubMed

    Repository · 98 publications · 4K citations

    35

    h-index

  4. British Journal of Haematology

    BJH · 57 publications · 2.9K citations

    32

    h-index

  5. Cancer

    45 publications · 2.3K citations

    30

    h-index

1–5